Display Settings:

Format

Send to:

Choose Destination
Rare Tumors. 2010 Mar 31;2(1):e9. doi: 10.4081/rt.2010.e9.

Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy.

Author information

  • 1University of Virginia, Department of Radiation Oncology;

Abstract

We report the case of a primary nasopharyngeal interdigitating dendritic cell tumor (IDDCT). A 25-year old male presented with bilateral decreased hearing, double vision, and ataxia. Flexible nasopharyngoscopy reviewed a large mass obstructing and filling the entire nasopharynx. MRI and PET-CT confirmed the presence of the primary tumor and demonstrated bilateral cervical lymphadenopathy. Biopsy of the nasopharynx revealed a hematolymphoid neoplasm with dendritic cell differentiation, most consistent with an IDDCT. The lesion was unresectable. The patient was treated with definitive radiotherapy to 66 Gy to the primary tumor and 50 Gy to the bilateral cervical lymphatics using an IMRT technique. A complete response was achieved and the patient remains disease free at the primary site 23 months after completion of radiotherapy.

KEYWORDS:

IDDCT; IMRT; extranodal; hematolymphoid neoplasm

PMID:
21139954
[PubMed]
PMCID:
PMC2994498
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk